2022-present Associate Professor, Department of Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
2015-2022 Assistant Professor, Department of Pharmacy Practice & Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
2014-2015 Post-Doctoral Fellow, Saint-Antoine Research Center, The National Institute of Health & Medical Research (INSERM), Pierre & Marie Curie (Paris VI) University, Sorbonne Universities, Paris, France
2013-2014 Post-Doctoral Fellow, Unit of Experimental Toxicology Unit, The French National Institute for Industrial Environment & Risks (INERIS), Vernueil-en-Halatte, France
2009-2012 PhD in Experimental & Clinical Pharmacology, The Drug Metabolism Research Laboratory (LEMM), Service of Pharmacology and Immunoanalysis (SPI), Institute of Biology and Technology Saclay (iBiTec-S), The French Alternative Energies & Atomic Energy Commission (CEA), Saclay, France
2008-2008 Master II Training in Pharmacology, The French National Centre for Scientific Research (CNRS), Faculty of Pharmacy, University of Strasbourg, Strasbourg, France
2024 Broca-Brisson L, Disdier C, Harati R, Hamoudi R, Mabondzo A. Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring. Front Neurosci. 2024 Apr 17;18:1362497. doi: 10.3389/fnins.2024.1362497. eCollection 2024.
2023 Banerjee SM, Acedo P, El Sheikh S, Harati R, Meecham A, Williams NR, Gerard G, Keshtgar MRS, MacRobert AJ, Hamoudi R. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer. Front Immunol. 2023 Nov 7;14:1188087. doi: 10.3389/fimmu. 2023. 1188087. eCollection 2023.
2023 Broca-Brisson L, Harati R, Disdier C, Mozner O, Gaston-Breton R, Maïza A, Costa N, Guyot AC, Sarkadi B, Apati A, Skelton MR, Madrange L, Yates F, Armengaud J, Hamoudi R, Mabondzo A. Deciphering neuronal deficit and protein profile changes in human brain organoids from patients with creatine transporter deficiency. Elife. 2023 Oct 13;12:RP88459. doi: 10.7554/eLife.88459.
2023 AlJayoush A, Hassan H, Asiri H, Jafar M, Saeed R, Harati R, Haider M. Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases. J Drug Deliv Sci Technol. Volume 89, November 2023, 105007.
2023 Osaid Z, Haider M, Hamoudi R, Harati R*. Exosomes Interactions with the Blood-Brain Barrier: Implications for Cerebral Disorders and Therapeutics. Int J Mol Sci. 2023 Oct 26;24(21):15635. doi: 10.3390/ijms242115635.
2023 Alsabbagh R, Ahmed M, Alqudah MAY, Hamoudi R, Harati R*. Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer. Cancers (Basel). 2023 Apr 12;15(8):2258. doi: 10.3390/cancers15082258.PMID: 37190188.
2023 Alnaqbi N, Mohammad MG, Hamoudi R, Mabondzo A, Harati R*. Molecular Heterogeneity of the Brain Endothelium. Curr Issues Mol Biol. 2023 Apr 16;45(4):3462-3478. doi: 10.3390/cimb45040227.PMID: 37185751.
2023 Abdelsalam M, Ahmed M, Osaid Z, Hamoudi R, Harati R*. Insights into Exosome Transport through the Blood-Brain Barrier and the Potential Therapeutical Applications in Brain Diseases. Pharmaceuticals (Basel). 2023 Apr 10;16(4):571. doi: 10.3390/ph16040571.PMID: 37111328.
2023 Mabondzo A, Harati R, Broca-Brisson L, Guyot AC, Costa N, Cacciante F, Putignano E, Baroncelli L, Skelton MR, Saab C, Martini E, Benech H, Joudinaud T, Gaillard JC, Armengaud J, Hamoudi R. Dodecyl creatine ester improves cognitive function and identifies key protein drivers including KIF1A and PLCB1 in a mouse model of creatine transporter deficiency. Front Mol Neurosci. 2023 Mar 24;16:1118707. doi: 10.3389/fnmol.2023.1118707. eCollection 2023.PMID: 37063368.
2022 Hammash D, Mahfood M, Khoder G, Ahmed M, Tlili A, Hamoudi R, Harati R*. miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells. Breast Cancer (Dove Med Press). 2022 Aug 1;14:187-198. doi: 10.2147/BCTT.S372083. eCollection 2022. PMID: 35936987.
2022 Harati R*, Hammad S, A Tlili, M Mahfood, Mabondzo A, Hamoudi R. MiR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability. PLoS One. 2022 Jan 13;17(1):e0262152. doi: 10.1371/journal.pone.0262152. eCollection 2022. PMID: 35025943.
• Supervision of Master Thesis in Pharmacology: “Enhancing anti-epileptic drug delivery to the brain: miR-27a as a potential therapeutic target to modulate P-glycoprotein expression at the blood-brain barrier”. M.Sc. candidate Saba Hammad. September 2020. Masters in Pharmaceutical Sciences (Pharmacology), College of Pharmacy, University of Sharjah.
• Supervision of Master Thesis in Pharmacology: “Evaluating the therapeutic potential of miR-623 to suppress extravasation of brain metastatic breast cancer cells”. M.Sc. candidate Duaa Hammash. September 2020. Masters in Pharmaceutical Sciences (Pharmacology), College of Pharmacy, University of Sharjah.
• Supervision of Master Thesis in Pharmacology: “Role of miR-let-7c in brain metastasis of triple negative breast cancer”. M.Sc. candidate Rama Al-Sabbagh. November 2020. Masters in Pharmaceutical Sciences (Pharmacology), College of Pharmacy, University of Sharjah.
• Supervision of Master Thesis in Pharmacology: “Role of exosomes in extravasation of brain metastatic triple negative breast cancer cells”. M.Sc. candidate Manal AbdelSalam. February 2020. Masters in Pharmaceutical Sciences (Pharmacology), College of Pharmacy, University of Sharjah.
• Co-Supervision of Master thesis: «Optimizing the Sorafenib treatment of hepatocellular carcinoma». M.Sc. candidate Amélie Maury. September 2014. Sorbonne Universities, Pierre & Marie Curie Faculty of Medicine, Paris, France